investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Pharmacogenetics of Phase II Drug Metabolizing Enzymes

Richard M Weinshilboum

2 Collaborator(s)

Funding source

National Institute of General Medical Sciences (NIH)

Liewei Wang

Mayo Clinic (Rochester)

Rochester, United States

Related projects

Sendurai A Mani

Pleiotropic Functions of FOXC2 in EMT, Stem Cells and Breast Cancer Progression

Breast

Dana Pe'Er

Integrative Cancer Genomics: Drivers, Pathways and Drugs

Breast

Kazuaki Takabe

Sphingosine-1-Phosphate in Breast Cancer Progression and Lymphangiogenesis

Breast

Thomas Westbrook

Discovering Genetic Networks of Triple-Negative Breast Cancer

Breast

Dihua Yu

Target p70S6K for Chemodietary Prevention/Early Intervention of ER- Breast Cancer

Breast

Calvin J Kuo

miR-126 Regulation of Tumor Progression

Breast

Colleen Ann Sweeney

LRIG Proteins in Mammary gland Development and Carcinogenesis

Breast

The Role of microRNA, mir-30d, in the Initiation and Progression of Cancer

Breast

Powel Brown

A MULTICENTER PHASE II STUDY OF DOCOSAHEXAENOIC ACID IN PATIENTS WITH A HISTORY OF BREAST CANCER, PREMALIGNANT LESIONS, OR BENIGN BREAST DISEASE

Breast